T. Rowe Price Investment Management, Inc. 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 10:06 am Purchase | 2026-03-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | T. Rowe Price Investment Management, Inc. | 2,162,684 9.500% | 2,162,684 (New Position) | Filing |